Promising Treatments for Cognitive Impairment
Summary of Presentation
Several pro-cognitive drugs are being developed and are currently in various review stages by the FDA. These new drugs have the potential to alter the outcome of many psychiatric disorders. They will offer new choices but also raise new challenges for the patient, their families and clinician, and our society.
Robert G. Stern, MD is Acting Medical Director of Essex County Hospital Center and is Clinical Associate Professor in the Department of Psychiatry at Rutgers University Robert Wood Johnson Medical School in Piscataway, NJ. For the past 30 years Dr. Stern’s clinical work and research have focused on the treatment of patients with severe mental illness in general and schizophrenia in particular. Dr. Stern has published over 100 articles, book chapters and abstracts. Dr. Stern graduated from Seckler School of Medicine, University of Tel Aviv and completed his residency training and fellowships at Mount Sinai School of Medicine in New York City. Dr. Stern is currently serving as the chairperson of the Public Psychiatry Committee of the New Jersey Psychiatric Association. Dr. Stern is the recipient of the 2012 NAMI Exemplary Psychiatrist Award.